ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

NC-Approved Clinical Trials

June 27, 2003

NCI Preliminary Budge For 1979 By Mechanism

June 3, 1977

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

Social Networks Influence Decision To Quit Smoking

May 30, 2008